our technology
RNA and DNA carriers from R&D grade to clinical applications
Lentiviral vectors for a stable expression
LentiFlash particles for non-integrative RNA delivery
lentiviral manufacturing platform
A continuum from research to clinical studies
applications of lentiviral technologies
The choice of lentiviral technology depends on your application
Gene editing Gene addition Immunotherapy Stable cell linesnews & events
Stay updated with our latest events and breaking news
News & events
-
"A New Paradigm in Drug Development"
17-09-2018Discover the article written by our CEO, Pascale Bouillé, in BioPharm International. -
Vectalys & Flashcell announce merger to create Flash Therapeutics
22-05-2018Vectalys & Flashcell merge and create Flash Therapeutics, a new gene therapy company. -
ASGCT 2018: Meet us in Chicago!
19-04-2018Vectalys will attend the ASGCT Annual Meeting, May 16-19, 2018 in Chicago, IL, USA.